| Financial Year |
March 31 2023 |
| Monetary Funds |
664,934,654.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
445,561,079.41 |
| Advances to Suppliers |
10,846,442.41 |
| Other Receivables |
139,536,905.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,763,472,165.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
43,989,189.06 |
| Total Current Assets |
6,068,340,436.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,501,436,646.09 |
| Investment Properties |
651,260,915.74 |
| Fixed Assetes |
11,524,681,444.42 |
| Under-construction Projects |
56,501,322.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,835,696,897.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,904,405.59 |
| Deferred Income Tax Assets |
359,028,173.15 |
| Other Non-Current Assets |
389,082,876.67 |
| Sub-Total of Non-Current Assets |
43,634,808,194.76 |
| Total Assets |
49,703,148,631.52 |
| Short-Term Loans |
3,977,797,354.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
527,767,773.52 |
| Accounts Received In Advance |
29,250,859.61 |
| Employee Compensation Payable |
66,905,129.12 |
| Taxes Payable |
217,522,666.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
649,906,894.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,148,860,471.37 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
9,680,107,918.68 |
| Long-term Loans |
23,482,801,539.30 |
| Bonds Payable |
499,588,587.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
982,803,555.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,000,784,401.55 |
| Total Liabilities |
35,680,892,320.23 |
| Paid-In Capital(Or Share Stock) |
2,247,371,832.00 |
| Capital Surplus |
1,342,098,787.51 |
| Surplus Reserve |
1,608,085,233.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,649,524,681.48 |
| Minority Stockholder's Interest |
31,281,297.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,990,975,014.06 |
| Owner's Equity（Stockholder's Equity） |
14,022,256,311.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
49,703,148,631.52 |
